Skip to main content
Erschienen in: Clinical Rheumatology 3/2004

01.06.2004 | Original Article

The prevalence of subclinical amyloidosis in Polish patients with rheumatoid arthritis

verfasst von: Piotr Wiland, Renata Wojtala, John Goodacre, Jacek Szechinski

Erschienen in: Clinical Rheumatology | Ausgabe 3/2004

Einloggen, um Zugang zu erhalten

Abstract

The aims of this study were to determine the proportion of rheumatoid arthritis (RA) patients attending hospital in whom amyloid deposits were present  in abdominal fat aspiration (AFA) samples, and to assess possible risk factors for amyloid development in RA. One -hundred and twenty-one patients (16 males, 105 females) with RA referred to the Department of Rheumatology in Wroclaw  between 1996  and 2001  were studied regardless of RA duration or laboratory findings. Abdominal subcutaneous fine-needle aspiration was performed, and samples of adipose tissue stained with alkaline Congo red then examined by polarized light microscopy. The presence or absence of amyloid fat deposits (AFD) was determined according to whether typical apple-green birefringence was observed. Amyloid deposits were found in 35 (29%) patients. Amyloidosis was significantly more common in males and in patients with longer disease duration. Patients with AFD had previously undergone less treatment with disease-modifying antirheumatic drugs (DMARDs) than those without AFD, and significantly fewer patients with AFD had previously taken methotrexate than those without AFD (25% vs 45%; p<0.01). Renal involvement was found in 12 of 35 patients with AFD (34%). Using the AFA technique, amyloid deposits were found commonly in RA patients, particularly in males with longer disease duration and in patients not treated intensively with DMARDs, especially methotrexate. AFA has potential useful application as a method for detecting amyloidosis before the overt occurrence of renal or other pathology related to amyloid deposits.
Literatur
1.
Zurück zum Zitat Gomez-Casanovas E, Sanmarti R, Sole M, Canete JD, Munoz-Gomez J (2001) The clinical significance of amyloid fat deposits in rheumatoid arthritis. Arthritis Rheum 44:66–72CrossRefPubMed Gomez-Casanovas E, Sanmarti R, Sole M, Canete JD, Munoz-Gomez J (2001) The clinical significance of amyloid fat deposits in rheumatoid arthritis. Arthritis Rheum 44:66–72CrossRefPubMed
2.
Zurück zum Zitat Calkins A, Cohen AS (1960) Diagnosis of amyloidosis. Bull Rheum Dis 10:215–218PubMed Calkins A, Cohen AS (1960) Diagnosis of amyloidosis. Bull Rheum Dis 10:215–218PubMed
3.
Zurück zum Zitat Westermark P, Stenkvist B (1973) A new method fot the diagnosis of systemic amyloidosis. Arch Intern Med 132:522–523CrossRefPubMed Westermark P, Stenkvist B (1973) A new method fot the diagnosis of systemic amyloidosis. Arch Intern Med 132:522–523CrossRefPubMed
4.
Zurück zum Zitat Laakso M, Mutru O, Isomaki H, Koota K (1986) Mortality from amyloidosis and renal disease in patients with rheumatoid arthritis. Ann Rheum Dis 45:663–667PubMed Laakso M, Mutru O, Isomaki H, Koota K (1986) Mortality from amyloidosis and renal disease in patients with rheumatoid arthritis. Ann Rheum Dis 45:663–667PubMed
5.
Zurück zum Zitat Nakano M, Ueno M, Nishi S et al. (1998) Analysis of renal pathology and drug history in 158 Japanese patients with rheumatoid arthritis. Clin Nephrol 50:154–160PubMed Nakano M, Ueno M, Nishi S et al. (1998) Analysis of renal pathology and drug history in 158 Japanese patients with rheumatoid arthritis. Clin Nephrol 50:154–160PubMed
6.
Zurück zum Zitat Kobayashi H, Tada S, Fuchigami T et al. (1996) Secondary amyloidosis in patients with rheumatoid arthritis: diagnostic and prognostic value of gastroduodenal biopsy. Br J Rheumatol 35:44–49 Kobayashi H, Tada S, Fuchigami T et al. (1996) Secondary amyloidosis in patients with rheumatoid arthritis: diagnostic and prognostic value of gastroduodenal biopsy. Br J Rheumatol 35:44–49
7.
Zurück zum Zitat Suzuki A, Ohoshone Y, Obana M et al. (1994) Cause of death in 81 autopsied patients with rheumatoid arthritis. J Rheumatol 21:33–36PubMed Suzuki A, Ohoshone Y, Obana M et al. (1994) Cause of death in 81 autopsied patients with rheumatoid arthritis. J Rheumatol 21:33–36PubMed
8.
Zurück zum Zitat Pettersson T, Törnroth T (1987) Fine needle aspiration biopsy from subcutaneous fat compared with rectal and renal biopsy in the detection of amyloid deposits. Scand J Rheumatol 16:388 Pettersson T, Törnroth T (1987) Fine needle aspiration biopsy from subcutaneous fat compared with rectal and renal biopsy in the detection of amyloid deposits. Scand J Rheumatol 16:388
9.
Zurück zum Zitat Klemi PJ, Sorsa S, Happonen RP (1987) Fine-needle aspiration biopsy from subcutaneous fat. An easy way to diagnose secondary amyloidosis. Scand J Rheumatol 16:429–431PubMed Klemi PJ, Sorsa S, Happonen RP (1987) Fine-needle aspiration biopsy from subcutaneous fat. An easy way to diagnose secondary amyloidosis. Scand J Rheumatol 16:429–431PubMed
10.
Zurück zum Zitat Falck HM, Tornroth T, Wegelius O (1983) Predominantly vascular amyloid deposition in the kidney in patients with minimal or no proteinuria. Clin Nephrol 19:137–139PubMed Falck HM, Tornroth T, Wegelius O (1983) Predominantly vascular amyloid deposition in the kidney in patients with minimal or no proteinuria. Clin Nephrol 19:137–139PubMed
11.
Zurück zum Zitat Tornroth T, Falck HM, Wafin F et al. (1980) Renal amyloidosis in rheumatic disease: A clinicopathological correlative study. In: Glenner GG, Costa PP, de Freitas AF (eds) Amyloid and amyloidosis. Excerpta Medica, Amsterdam, pp 191–199 Tornroth T, Falck HM, Wafin F et al. (1980) Renal amyloidosis in rheumatic disease: A clinicopathological correlative study. In: Glenner GG, Costa PP, de Freitas AF (eds) Amyloid and amyloidosis. Excerpta Medica, Amsterdam, pp 191–199
12.
Zurück zum Zitat Bourke BE, Woodrow DF, Scott JT (1981) Proteinuria in rheumatoid arthritis – drug-induced or amyloid ? Ann Rheum Dis 40:240–244PubMed Bourke BE, Woodrow DF, Scott JT (1981) Proteinuria in rheumatoid arthritis – drug-induced or amyloid ? Ann Rheum Dis 40:240–244PubMed
13.
Zurück zum Zitat Heikki J. Helin, Markku M et al. (1995) Renal biopsy findings and clinicopathologic correlations in rheumatoid arthritis. Arthritis Rheum 38:242–247PubMed Heikki J. Helin, Markku M et al. (1995) Renal biopsy findings and clinicopathologic correlations in rheumatoid arthritis. Arthritis Rheum 38:242–247PubMed
14.
Zurück zum Zitat Michels H, Linke RP (1996) Development of amyloidosis as an unrecognized side effect of gold therapy: comment on the article by Shapiro and Spiera. Arthritis Rheum 39:1932–1934PubMed Michels H, Linke RP (1996) Development of amyloidosis as an unrecognized side effect of gold therapy: comment on the article by Shapiro and Spiera. Arthritis Rheum 39:1932–1934PubMed
15.
Zurück zum Zitat Pãi S, Helin H, Isomãki H (1993) Frequency of amyloidosis in Estonian patients with rheumatoid arthritis. Scand J Rheumatol 22:248–249PubMed Pãi S, Helin H, Isomãki H (1993) Frequency of amyloidosis in Estonian patients with rheumatoid arthritis. Scand J Rheumatol 22:248–249PubMed
16.
Zurück zum Zitat El Mansoury TM, Hazenberg BPC, El Badawy SA et al. (2002) Screening for amyloid in subcutaneous fat tissue of Egyptian patients with rheumatoid arthritis: clinical and laboratory characteristics. Ann Rheum Dis 61:42–47CrossRefPubMed El Mansoury TM, Hazenberg BPC, El Badawy SA et al. (2002) Screening for amyloid  in subcutaneous fat tissue of Egyptian patients with rheumatoid arthritis: clinical and laboratory characteristics. Ann Rheum Dis 61:42–47CrossRefPubMed
17.
Zurück zum Zitat Titinen S, Kaarela K, Helin H, Kautiainen H, Isomãki H (1993) Amyloidosis – incidence and early risk factors in patients with rheumatoid arthritis. Scand J Rheumatol 22:158–161PubMed Titinen S, Kaarela K, Helin H, Kautiainen H, Isomãki H (1993) Amyloidosis – incidence and early risk factors in patients with rheumatoid arthritis. Scand J Rheumatol 22:158–161PubMed
18.
Zurück zum Zitat Myllykangas-Luosujarvi R, Aho K, Kautiainen H, Hakala M (1999) Amyloidosis in a nationwide series of 1666 subjects with rheumatoid arthritis who died during 1989 in Finland. Rheumatology 38:499–503CrossRefPubMed Myllykangas-Luosujarvi R, Aho K, Kautiainen H, Hakala M (1999) Amyloidosis in a nationwide series of 1666 subjects with rheumatoid arthritis who died during 1989 in Finland. Rheumatology 38:499–503CrossRefPubMed
19.
Zurück zum Zitat Barile L, Ariza R, Muci H et al. (1993) Tru-cut needle biopsy of subcutaneous fat in the diagnosis of secondary amyloidosis in rheumatoid arthritis. Arch Med Res 24:189–192PubMed Barile L, Ariza R, Muci H et al. (1993) Tru-cut needle biopsy of subcutaneous fat in the diagnosis of secondary amyloidosis in rheumatoid arthritis. Arch Med Res 24:189–192PubMed
20.
Zurück zum Zitat Hazenberg BPC, van Rijswijk MH (2000) Where has secondary amyloid gone? [Editorial] Ann Rheum Dis 59:577–579 Hazenberg BPC, van Rijswijk MH (2000) Where has secondary amyloid gone? [Editorial] Ann Rheum Dis 59:577–579
21.
Zurück zum Zitat Prokaeva TB, Alekberova ZS, Radenska-Lopovok SG, Tiitinen S, Kaarela K, Kautiainen H (1995) Does the basic therapy affect the development of secondary amyloidosis in rheumatoid arthritis ? Ter Arkh 67:47–49 Prokaeva TB, Alekberova ZS, Radenska-Lopovok SG, Tiitinen S, Kaarela K, Kautiainen H (1995) Does  the basic therapy affect the development of secondary amyloidosis in rheumatoid arthritis ? Ter Arkh 67:47–49
22.
Zurück zum Zitat Hall CL, Fothergill NJ, Blackwell MM, Harrison PR, MacKenzie JC, MacIver AG (1987) The natural course of gold nephropathy: long term study of 21 patients. Br Med J 295:745–748 Hall CL, Fothergill NJ, Blackwell MM, Harrison PR, MacKenzie JC, MacIver AG (1987) The natural course of gold nephropathy: long term study of 21 patients. Br Med J 295:745–748
23.
Zurück zum Zitat Hall CL, Jawad S, Harrison PR et al. (1988) Natural course of penicillamine nephropathy: a long term study of 33 patients. Br Med J 296:1083–1086 Hall CL, Jawad S, Harrison PR et al. (1988) Natural course of penicillamine nephropathy: a long term study of 33 patients. Br Med J 296:1083–1086
24.
Zurück zum Zitat Shapiro DL, Spiera H (1995) Regression of the nephrotic syndrome in rheumatoid arthritis and amyloidosis treated with azathioprine. A case report. Arthritis Rheum 38:1851–1854PubMed Shapiro DL, Spiera H (1995) Regression of the nephrotic syndrome in rheumatoid arthritis and amyloidosis treated with azathioprine. A case report. Arthritis Rheum 38:1851–1854PubMed
25.
Zurück zum Zitat Berglund K, Thysell H, Keller C (1993) Results, principles and pitfalls in the management of renal AA-amyloidosis: a 10–21 year followup of 16 patients with rheumatic disease treated with alkylating cytostatics. J Rheumatol 20:2051–2057PubMed Berglund K, Thysell H, Keller C (1993) Results, principles and pitfalls in the management of renal AA-amyloidosis: a 10–21 year followup of 16 patients with rheumatic disease treated with alkylating cytostatics. J Rheumatol 20:2051–2057PubMed
26.
Zurück zum Zitat Mpofu S, Teh LS, Smith PJ, Moots RJ, Hawkins PN (2003) Cytostatic therapy for AA amyloidosis complicating psoriatic spondyloarthropathy. Rheumatology 42:362–366CrossRefPubMed Mpofu S, Teh LS, Smith PJ, Moots RJ, Hawkins PN (2003) Cytostatic therapy for AA amyloidosis complicating psoriatic spondyloarthropathy. Rheumatology 42:362–366CrossRefPubMed
27.
Zurück zum Zitat Chevrel G, Jenvrin C, McGregor B, Miossec P (2001) Renal type AA amyloidosis associated with rheumatoid arthritis: a cohort study showing improved survival on treatment with pulse cyclophosphamide. Rheumatology 40:821–825CrossRefPubMed Chevrel G, Jenvrin C, McGregor B, Miossec P (2001) Renal type AA amyloidosis associated with rheumatoid arthritis: a cohort study showing improved survival on treatment with pulse cyclophosphamide. Rheumatology 40:821–825CrossRefPubMed
28.
Zurück zum Zitat Gertz MA, Kyle RA (1991) Secondary systemic amyloidosis: response and survival in 64 patients. Medicine (Baltimore) 70:246–256 Gertz MA, Kyle RA (1991) Secondary systemic amyloidosis: response and survival in 64 patients. Medicine (Baltimore) 70:246–256
29.
Zurück zum Zitat Fiter J Nolla JM, Valverde J, Roig Escofet D (1995) Methotrexate treatment of amyloidosis secondary to rheumatoid arthritis. Rev Clin Esp 195:390–392PubMed Fiter J Nolla JM, Valverde J, Roig Escofet D (1995) Methotrexate treatment of amyloidosis secondary to rheumatoid arthritis. Rev Clin Esp 195:390–392PubMed
30.
Zurück zum Zitat Martinez MS, Garcia-Monforte A, Rivera J(2001) Survival study of rheumatoid arthritis patients in Madrid. Scand J Rheumatol ;30:195–198 Martinez MS, Garcia-Monforte A, Rivera J(2001) Survival study of rheumatoid arthritis patients in Madrid. Scand J Rheumatol ;30:195–198
31.
Zurück zum Zitat Kaipiainen-Seppanen O, Myllykangas-Luosujarvi R, Lampainen E, Ikaheimo R (2000) Intensive treatment of rheumatoid arthritis reduces need for dialysis due to secondary amyloidosis. Scand J Rheumatol 29:232–235CrossRefPubMed Kaipiainen-Seppanen O, Myllykangas-Luosujarvi R, Lampainen E, Ikaheimo R (2000) Intensive treatment of rheumatoid arthritis reduces need for dialysis due to secondary amyloidosis. Scand J Rheumatol 29:232–235CrossRefPubMed
32.
Zurück zum Zitat Gillmore JD, Lovat LB, Persey MR, Pepys MB, Hawkins PN (2001) Amyloid load and clinical outcome in AA amyloidosis in relation to circulating concentration of serum amyloid A protein. Lancet 358:24–29CrossRefPubMed Gillmore JD, Lovat LB, Persey MR, Pepys MB, Hawkins PN (2001) Amyloid load and clinical outcome in AA amyloidosis in relation to circulating concentration of serum amyloid A protein. Lancet 358:24–29CrossRefPubMed
33.
Zurück zum Zitat Laiho K, Tiitinen S, Kaarela K, Helin H, Isomaki H (1999) Secondary amyloidosis has decreased in patients with inflammatory joint disease in Finland. Clin Rheumatol 18:122–123CrossRefPubMed Laiho K, Tiitinen S, Kaarela K, Helin H, Isomaki H (1999) Secondary amyloidosis has decreased in patients with inflammatory joint disease in Finland. Clin Rheumatol 18:122–123CrossRefPubMed
Metadaten
Titel
The prevalence of subclinical amyloidosis in Polish patients with rheumatoid arthritis
verfasst von
Piotr Wiland
Renata Wojtala
John Goodacre
Jacek Szechinski
Publikationsdatum
01.06.2004
Verlag
Springer-Verlag
Erschienen in
Clinical Rheumatology / Ausgabe 3/2004
Print ISSN: 0770-3198
Elektronische ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-003-0842-y

Weitere Artikel der Ausgabe 3/2004

Clinical Rheumatology 3/2004 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren. 

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.